Suchergebnisse - (Subject:"Siltuximab")

PubPharm (15)

1

Advances in clinical outcomes : What we have learned during the COVID-19 pandemic

enthalten in: The Journal of allergy and clinical immunology | 2022

von Al-Musa, A. | LaBere, B. | Habiballah, S. | +2

2

Population pharmacokinetics of siltuximab : impact of disease state

enthalten in: Cancer chemotherapy and pharmacology | 2019

von Nikanjam, M. | Yang, J. | Capparelli, E.

3

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Hematology. American Society of Hematology. Education Program | 2018

von Fajgenbaum, D.

4

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von Fajgenbaum, D.

5

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

6

Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease

enthalten in: Blood | 2017

von Yu, L. | Tu, M. | Cortes, J. | +13

CommentIn: Blood. 2017 Mar 23;129(12 ):1570. - PMID 28336728

7

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy

enthalten in: Journal of immunological methods | 2016

von Chen, F. | Teachey, D. | Pequignot, E. | +7

8

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma : an open-label phase I trial

enthalten in: Blood cancer journal | 2016

von Shah, J. | Feng, L. | Thomas, S. | +8

9

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2014

von Song, L. | Smith, M. | Doshi, P. | +4

10

Paraneoplastic thrombocytosis in ovarian cancer

enthalten in: The New England journal of medicine | 2012

von Stone, R. | Nick, A. | McNeish, I. | +31

ErratumIn: N Engl J Med. 2012 Nov;367(18):1768 Lamkin, Donald [added]